PSPerry Shen

Perry Shen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Perry Shen has a total of 199 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Readmissions After Surgery for Colorectal Liver Metastases: A Propensity Score Analysis From the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC)

    by Heidy Cos, Cristian D. Valenzuela, Omeed Moaven, Grey Leonard, John Stauffer, Nico R. Del Piccolo, Tan To Cheung, Carlos U. Corvera, Andrew Wisneski, Charles Cha, et al.

    Background: Readmission is considered as a surgical quality indicator. More data regarding predictors of readmission and outcomes after surgery for colorectal liver metastasis are needed. Using a propensity score match to create a 1:2 match of cases:controls for 90‐day. Readmission, the matching variables used for balance included age, tumor size, estimated blood loss, and type of resection (minor or major). T‐tests were used for continuous measures, Fisher's exact test was used for categorical data, and the Kaplan–Meier method was used to estimate survival. p < 0.05 was considered significant. Methods: Retrospectively examined 935 patients with CLM from 2000 to 2018. Using a propensity score match to create a 1:2 match of cases:controls for 90‐day. Readmission, the matching variables used for balance included age, tumor size, estimated blood loss, and type of resection (minor or major). T‐tests were used for continuous measures, Fisher's exact test was used for categorical data, and the Kaplan–Meier method was used to estimate survival. p < 0.05 was considered significant. Results: 935 patients were included in the initial sample with 896 eligible for inclusion in the propensity matching. The average age of the population was 59% and 59% male. Overall readmission rate was 8.0%. Median time to readmission was 14 days. In the propensity score matched sample, readmitted patients had higher rates of organ space infection (28% vs 2% and p < 0.0001), bile leak (26% vs 1% and p < 0.0001), and liver failure (9% vs 2% and p = 0.042). There was no difference in LOS (7 days versus six days and p = 0.40), overall survival (median 39.7 vs 41.0 months and p = 0.79), or rate of adjuvant therapy (68% for both and p > 0.99). Conclusion: Patients readmitted for intermediate and late complications after surgery for CLM can recover and receive adjuvant therapy with no adverse effect on overall survival. Organ space infection, bile leak, and liver failure are highly associated with readmission.

  • Outcomes for Gastrectomy During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongastric Primaries: 30-Year Experience

    by Heidy Cos, Greg Bs Russell, Kathleen Bs Perry, Konstantinos I Votanopoulos, Edward A Levine, Perry Md Shen

    BACKGROUND: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can improve survival for patients with peritoneal surface malignancy. Completeness of cytoreduction correlates with prognosis. The role of gastrectomy in these patients is not well described. STUDY DESIGN: A total of 1868 patients who underwent CRS+HIPEC for nongastric primary between 1991 and 2024 were analyzed from a prospective database. Patients were stratified by gastrectomy extent and their outcomes compared with no-gastrectomy patients. Continuous variables are presented as mean (SD), categorical variables as N (%), and values considered statistically significant at <0.05. RESULTS: No differences were observed in baseline demographics between the gastrectomy and no-gastrectomy groups. There were 23 major, 45 distal, and 77 wedge gastrectomies (n = 145, 7.76%). Appendiceal was the most common neoplasm in the gastrectomy groups (major: 96%, distal: 91%, wedge: 68%, no gastrectomy: 53%). Gastrectomy patients had higher median peritoneal carcinomatosis index (PCI) (major: 27 [7.0], distal: 24 [7.0], wedge: 19 [10.3], no-gastrectomy: 14 [9.5]; p < 0.001), R2 resection (major: 96%, distal: 89%, wedge: 60%, no-gastrectomy: 45%; p < 0.001), severe complications (major: 30%, distal: 27%, wedge: 19%, no-gastrectomy: 12%; p < 0.001), length of stay (major: 24 [15.2], distal: 23 [25.7], wedge: 18 [22.2], no-gastrectomy: 12 [12.5] days; p < 0.001), and 30-day mortality (major: 17%, distal: 11%, wedge: 10%, no-gastrectomy: 5%; p < 0.001). There was no difference in 30-day readmission or recurrence. On multivariate analysis, gastrectomy was not independently associated with overall survival (p = 0.18). CONCLUSIONS: Approximately 8% of patients who underwent CRS+HIPEC for nongastric primaries underwent gastrectomy. Gastrectomy patients were more likely to have higher PCI and incomplete resections with increased complications and mortality. PCI, resection status, lymph nodes, tumor grade, and primary site, but not gastrectomy type, are significantly associated with overall survival.

  • Surgical Approach and Length of Stay in Octogenarians Undergoing Pancreatic Resection for Malignancy

    by Grey Leonard, Ian Solsky, Clancy Clark, Perry Shen

    Introduction: Pancreatic surgery often has a lengthy recovery in the elderly. Minimally invasive surgery (MIS) can decrease length of stay (LOS), but it is unknown if this benefit applies to octogenarians (Age > 79).Methods: The NSQIP database was used to determine if MIS approaches were associated with reduced LOS among octogenarians undergoing pancreaticoduodenectomy (Whipple) or distal pancreatectomy (Distal). Operative approaches were classified as “Open” or “MIS” and propensity score (PS) matching was performed.Results: For the Whipple, 1665 Open and 101 MIS procedures occurred (median LOS 9, 8 days, p = 0.584). For Distal, 472 Open and 223 MIS procedures occurred (median LOS 6, 5 days, p < 0.01). After PS matching, there were 202 Whipple (101 per group) and 446 Distal (223 per group) patients. There was no difference in LOS by approach in the Whipple group (p = 0.546). The median LOS was 9 (IQR 7–15), Open and 8 (IQR 6–13), MIS. For Distal, there was a difference in LOS in the Open versus MIS approach (p < 0.01) and the median LOS was 6 (IQR 5–8) and 5 (IQR 4–6).Conclusions: Among octogenarians the MIS approach was associated with decreased LOS in distal pancreatectomies, but not in pancreaticoduodenectomies.


  • Prognostic implications of margin status in association with systemic treatment in a cohort study of patients with resection of colorectal liver metastases

    by Omeed Moaven, Bigyan B. Mainali, Cristian D. Valenzuela, Gregory Russell, Tanto Cheung, Carlos U. Corvera, Andrew D. Wisneski, Charles H. Cha, John A. Stauffer, Perry Shen

    Background: This study investigates the impact of margin status after colorectal liver metastasis (CLM) resection on outcomes of patients after neoadjuvant treatment versus those who underwent upfront resection.Methods: An international collaborative database of CLM patients who underwent surgical resection was used. Proportional hazard regression models were created for single and multivariable models to assess the relationship between independent measures and median overall survival (mOS).Results: R1 was associated with worse OS in the neoadjuvant group (mOS: 51.8 m for R0 vs. 26.0 m for R1; HR: 2.18). In the patients who underwent upfront surgery, R1 was not associated with OS. (mOS: 46.7 m for R0 vs. 42.6 m for R1). When patients with R1 in each group were stratified by adjuvant treatment, there was no significant difference in the neoadjuvant group, while in the upfront surgery group with R1, adjuvant treatment was associated with significant improvement in OS (mOS: 42.6 m for adjuvant vs. 25.0 m for no adjuvant treatment; HR: 0.21).Conclusion: R1 is associated with worse outcomes in the patients who receive neoadjuvant treatment with no significant improvement with the addition of adjuvant therapy, likely representing an aggressive tumor biology. R1 did not impact OS in patients with upfront surgery who received postoperative chemotherapy.

  • Resection versus resection with ablation: Analysis from the colorectal liver operative metastasis international collaborative

    by Bigyan B. Mainali, Cristian D. Valenzuela, Omeed Moaven, John A. Stauffer, Nico R. Del Piccolo, Tanto Cheung, Carlos U. Corvera, Andrew D. Wisneski, Charles H. Cha, Nima P. Zarandi, et al.

    Background: Thermal ablation has recently become a key therapy for the treatment of colorectal liver metastasis (CLM). However, the role of ablation in combination with resection has not yet been firmly established. We hypothesize that in patients with CLM, those who undergo liver resection with ablation (RA) have similar outcomes compared with those who undergo liver resection only.Methods: We reviewed a multicenter international database of 906 surgical procedures for CLM from 5 high volume hepatobiliary surgical units. Patients undergoing RA (n = 63) were matched based on the number of lesions and tumor size using a 1:1 balanced propensity score analysis with those having resection only (n = 63). Our primary outcomes were overall survival (OS) and disease‐free survival (DFS).Results: The mean age of our cohort was 58 ± 11 years, with 43% females. With a median follow‐up of 70.8 months, patients in the resection and RA group had a median OS of 45.1 and 54.8 months (p = 0.71), respectively. The median DFS was 22.7 and 14.2 months (p = 0.045), respectively. Using a multivariate Cox proportional hazards regression model, the treatment approach was not associated with OS (p = 0.94) or DFS (p = 0.059). A higher number of lesions is independently associated with worse DFS (hazard ratio: 1.12, p < 0.01). When there was disease recurrence, the region of recurrence was similar between the RA versus resection only groups (p = 0.27), but there was a shorter time to recurrence in the RA group (p = 0.002).Conclusion: For CLM, the treatment approach was not significantly associated with OS or DFS, while tumor biology likely played an important role. Prospective research on the quality and effectiveness of thermal ablation combined with hepatic resection is warranted.


  • ASO Visual Abstract: Distance Traveled and Disparities in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    by Ian Solsky, Ana Patel, Grey Leonard, Gregory Russell, Kathleen Perry, Konstantinos I. Votanopoulos, Perry Shen, Edward A. Levine

  • Open Access

    Comparison of outcomes between surgical treatment of colorectal cancer metastatic to the liver and the peritoneum: Review of the literature

    by Heidy Cos, Perry Shen

    Background: Liver and peritoneum are two of the most common sites of colorectal metastases.Methods: We searched for articles comparing outcomes of surgical management for metastatic colorectal cancer to the liver and peritoneum.Conclusion: Cytoreductive surgery/heated intraperitoneal chemotherapy has a similar safety profile and survival outcomes as hepatectomy for colorectal metastases after stratifying by resection status and should be incorporated earlier in the management algorithm for colorectal cancer patients with peritoneal metastasesMethods: We performed a wide search on PubMed, EMBASE, and Google Scholar for articles comparing outcomes of surgical management for metastatic colorectal cancer to the liver and peritoneum. We focused on studies comparing their perioperative clinical outcomes as well as their oncological outcomes. The following words were included in the search: comparison, outcomes, metastasectomy, colorectal cancer, liver, peritoneal surface disease, hepatectomy, and cytoreduction.Results: One hundred and twenty studies were evaluated. Six of these studies met the criteria for this review.


  • ASO Visual Abstract: Survival Outcomes of Optimally Treated Colorectal Metastases–The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease

    by Ian Solsky, Omeed Moaven, Cristian D. Valenzuela, Megan Lundy, John A. Stauffer, Nico R. Del Piccolo, Tanto Cheung, Carlos U. Corvera, Andrew D. Wisneski, Charles Cha, et al.

  • ASO Visual Abstract: Conditional Survival After Hepatectomy for Colorectal Liver Metastasis—Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC)

    by Cristian D. Valenzuela, Omeed Moaven, Ian B. Solsky, John A. Stauffer, Nico R. Del Piccolo, Tanto Cheung, Carlos U. Corvera, Andrew D. Wisneski, Charles H. Cha, Nima P. Zarandi, et al.